Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial

This publication has 44 references indexed in Scilit:

• Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review
  Diabetes Therapy, 2024
• Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease
  JAMA Network Open, 2024
• The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions
  Annals of Vascular Surgery, 2024
• Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication
  European Journal of Vascular and Endovascular Surgery, 2023
• Pathology, Progression, and Emerging Treatments of Peripheral Artery Disease–Related Limb Ischemia
  Clinical Therapeutics, 2023
• Telmisartan and Walking Performance in Peripheral Artery Disease
  JAMA, 2022
• Body mass index and peripheral artery disease
  Atherosclerosis, 2020
• Low ankle brachial index is associated with the magnitude of impaired walking endurance in patients with heart failure
  International Journal of Cardiology, 2016
• Functional Decline in Peripheral Arterial Disease
  JAMA, 2004
• A New Pharmacological Treatment for Intermittent Claudication:
  Archives of internal medicine (1960), 1999